cognitive cybersecurity intelligence

News and Analysis

Search

Cambrex Inks Deal with Lilly to Support Biotech Collaborator Manufacturing

Cambrex, a contract development and manufacturing organisation (CDMO), has partnered with developmental biotechnology firm Eli Lilly to offer improved access to clinical development capabilities. Working with Lilly’s early external innovation and collaboration arm, Lilly Catalyze360-ExploR&D, Cambrex will offer drug substance, product, R&D and analytical service labs to Lilly’s collaborators. Cambrex’s Longmont facility will host the primary services.

Source: www.genengnews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts